These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. On the structure-based design of novel inhibitors of H5N1 influenza A virus neuraminidase (NA). Mitrasinovic PM Biophys Chem; 2009 Mar; 140(1-3):35-8. PubMed ID: 19117662 [TBL] [Abstract][Full Text] [Related]
28. [What do your patients want to know now? The most frequent questions about avian influenza]. MMW Fortschr Med; 2006 Mar; 148(9):13. PubMed ID: 16566386 [No Abstract] [Full Text] [Related]
29. [The role of the occupational physician in the prevention of the spreading of H5N1 virus avian influenza in exposed workers]. Di Lorenzo L; Soleo L Med Lav; 2006; 97(1):63-9. PubMed ID: 17009673 [TBL] [Abstract][Full Text] [Related]
30. Antiviral treatment and prophylaxis of influenza in primary care: German recommendations. Wutzler P; Kossow KD; Lode H; Ruf BR; Scholz H; Vogel GE; J Clin Virol; 2004 Oct; 31(2):84-91. PubMed ID: 15364262 [TBL] [Abstract][Full Text] [Related]
31. [Avian influenza and oseltamivir; a retrospective view]. Galama JM Ned Tijdschr Geneeskd; 2003 Jun; 147(23):1100-2. PubMed ID: 12822517 [TBL] [Abstract][Full Text] [Related]
32. No evidence of transmission of H5N1 highly pathogenic avian influenza to humans after unprotected contact with infected wild swans. Wallensten A; Salter M; Bennett S; Brown I; Hoschler K; Oliver I Epidemiol Infect; 2010 Feb; 138(2):210-3. PubMed ID: 19765331 [TBL] [Abstract][Full Text] [Related]
33. Influenza: current threat from avian influenza. Stephenson I; Democratis J Br Med Bull; 2005; 75-76():63-80. PubMed ID: 16651383 [TBL] [Abstract][Full Text] [Related]
34. [The first confirmed human case of avian influenza A (H5N1) in mainland, China]. Yu HJ; Chen YX; Shu YL; Li JH; Gao ZC; Hu SX; Dong J; Zhang H; Xiang NJ; Zhang Y; Hu YH; Xu CL; Gao LD; Wang M; Li ZJ; Zhou L; Liu ZT; Li DX; Wang MW; Wang ZJ; Wang Y; Yang WZ Zhonghua Liu Xing Bing Xue Za Zhi; 2006 Apr; 27(4):281-7. PubMed ID: 16875527 [TBL] [Abstract][Full Text] [Related]
35. Evolution of drug resistance in multiple distinct lineages of H5N1 avian influenza. Hill AW; Guralnick RP; Wilson MJ; Habib F; Janies D Infect Genet Evol; 2009 Mar; 9(2):169-78. PubMed ID: 19022400 [TBL] [Abstract][Full Text] [Related]
36. The spread of avian influenza H5N1 virus; a pandemic threat to mankind. Chutinimitkul S; Payungporn S; Chieochansin T; Suwannakarn K; Theamboonlers A; Poovorawan Y J Med Assoc Thai; 2006 Sep; 89 Suppl 3():S218-33. PubMed ID: 17722309 [TBL] [Abstract][Full Text] [Related]
37. [Human and avian influenza due to the H5N1 virus]. Durand MP Sante; 2007; 17(1):3-10. PubMed ID: 17897895 [TBL] [Abstract][Full Text] [Related]
38. [Encephalitis and encephalopathy associated with pandemic flu]. Tamaki R; Kamigaki T; Oshitani H Brain Nerve; 2009 Feb; 61(2):153-60. PubMed ID: 19235465 [TBL] [Abstract][Full Text] [Related]
39. [Neuraminidase inhibitors in therapy of influenza]. Fladerer P; Wenisch C Acta Med Austriaca; 2000; 27(5):133-40. PubMed ID: 11261262 [TBL] [Abstract][Full Text] [Related]
40. Contact variables for exposure to avian influenza H5N1 virus at the human-animal interface. Rabinowitz P; Perdue M; Mumford E Zoonoses Public Health; 2010 Jun; 57(4):227-38. PubMed ID: 19486500 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]